Skip to main content

Table 5 Locoregional recurrence within HR-/HER2- subtype by presence of lymphovascular invasion (LVI) (Number = 80)

From: Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy

Variable

Locoregional recurrence

No recurrence

LRR probability at 60 month

P-value

LVI positive

4

12

29.7%

 

LVI negative

6

58

9.2%

0.04